Every Thursday we send out a curated newsletter on all things femtech and women’s health innovation. This is an excerpt from the latest edition. If you’d like to subscribe, you can do so at the bottom of this page.

Nevia Bio specializes in developing machine learning algorithms capable of identifying early indicators of women’s health issues, such as ovarian cancer. Image: Nevia Bio


Nevia Bio secures $3M in seed funding to advance machine learning in women’s health diagnostics.

Questa Capital secures $397M for Fund III to invest in healthcare transformation.

Sonio receives FDA clearance for its AI-powered prenatal ultrasound solution.

Maven Clinic and March for Moms unveil the second cohort of MPact for Families fellows to advance maternal health equity.

Movana Health submits FDA application for Evie Ring, its clinical-grade wearable for women.

Progyny partners with Gennev and Midi Health to offer menopause care in the US.

In the Know

The Future of Contraception (Femtech Insider)

An economic case for a more women-centric health care system (Deloitte)

The booming menopause economy has its very own aesthetic (FastCompany)

Misinformation, misogyny, and money: how community could be the key to unlock femtech (Maddyness)

Women-led firms are a bright spot in 2023’s fundraising slump (TechCrunch)

Femtech is transforming women’s healthcare. But it must include everyone (World Economic Forum)

Medical illustrations have a representation problem – it can be fatal (FastCompany)

Show CommentsClose Comments

Leave a comment